The effect of calcium and magnesium ions on urinary urokinase and sialidase activity. 1992

C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
Department of Urology, HF Verwoerd Hospital, University of Pretoria, Republic of South Africa.

The effect of a promoter (calcium) and an inhibitor (magnesium) of urolithiasis was spectrophotometrically studied on urokinase (0.45 IU) and sialidase (5 mM). Although these mineral did not affect the sialidase activity, total inhibition of urokinase activity was observed with either 0.05 M calcium chloride or 0.1 M magnesium chloride. This observation might explain why calcium and magnesium respectively function as a promoter and an inhibitor of stone formation.

UI MeSH Term Description Entries
D007669 Kidney Calculi Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE. Kidney Stones,Renal Calculi,Nephrolith,Renal Calculus,Calculi, Kidney,Calculi, Renal,Calculus, Kidney,Calculus, Renal,Kidney Calculus,Kidney Stone,Stone, Kidney,Stones, Kidney
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
August 1977, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
May 1954, The Journal of physiology,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
July 2010, Die Pharmazie,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
September 1972, European journal of pharmacology,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
January 1981, The Journal of rheumatology,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
August 2020, Food chemistry,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
January 1971, Tsitologiia,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
May 1991, Journal of comparative pathology,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
February 1965, New Zealand veterinary journal,
C H van Aswegen, and J C Dirksen van Sckalckwyk, and P J du Toit, and L Verster, and R C Franz, and D J du Plessis
July 1948, The Journal of clinical investigation,
Copied contents to your clipboard!